Advertisement Drug Licensing Activity Report Q1 2010 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Whitepapers

Drug Licensing Activity Report Q1 2010

After a stellar rise in Q4 2009, the total value of drug licensing agreements has taken a nosedive in
Q1 2010. The quarter has seen 133 agreements valued at USD 8.4bn, a staggering decrease of 52% by value from Q4 2009, in which 146 agreements with a total value of USD 17.4bn were announced.

Download whitepaper

Enter your details to get your free whitepaper:


Submit

I have read and accept the terms and conditions and privacy policy.

receive-email We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.

third-party If you would like to hear from carefully selected third party companies, check this box.

company-follow Follow this company to receive notifications when they update.


More from